Susan J. Ramus

IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression, achieving 85% accuracy in TCGA and 91% in an independent cohort.

This study uses exome sequencing to identify HELB as a novel susceptibility gene for non-high grade serous epithelial ovarian cancer, with a strong association found in genetic analyses.

The paper develops a multifactorial risk model for epithelial tubo-ovarian cancer incorporating genetic and epidemiological factors to stratify risk and guide screening.

This study improves transcriptome-wide association studies by integrating pleiotropy-guided methods with GWAS data to identify new cancer susceptibility genes.

This study combines genome-wide association data from four cancers to identify shared and novel genetic associations and pleiotropic effects.